Neuralstem, Inc. Press Releases

CUR 
$3.46
*  
0.07
2.06%
Get CUR Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading CUR now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Neuralstem Added To Russell 3000 Index
6/30/2014 9:15:00 AM - PR Newswire

Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder
6/25/2014 9:15:00 AM - PR Newswire

Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress
6/19/2014 9:15:00 AM - PR Newswire

Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting
6/18/2014 9:15:00 AM - PR Newswire

DiagnoCure announces second quarter 2014 results
6/4/2014 5:01:00 PM - PR Newswire

Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting
5/23/2014 9:28:00 AM - PR Newswire

Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and Give Update on Trials
5/16/2014 9:15:00 AM - PR Newswire

Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
5/12/2014 9:15:00 AM - PR Newswire

Technical Data on Top Gainers -- Research on Assured Guaranty, Ampio Pharma, Neuralstem, and Kennedy-Wilson Holdings
5/9/2014 1:34:00 PM - PR Newswire

Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors
5/8/2014 9:15:00 AM - PR Newswire

DiagnoCure announces results of its Annual General and Special Meeting of shareholders
4/17/2014 5:18:00 PM - PR Newswire

Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego
4/16/2014 9:15:00 AM - PR Newswire